BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jagtap P, Soriano FG, Virág L, Liaudet L, Mabley J, Szabó É, Haskó G, Marton A, Lorigados CB, Gallyas F, Sümegi B, Hoyt DG, Baloglu E, Vanduzer J, Salzman AL, Southan GJ, Szabó C. Novel phenanthridinone inhibitors of poly(adenosine 5′-diphosphate-ribose) synthetase: Potent cytoprotective and antishock agents*: . Critical Care Medicine 2002;30:1071-82. [DOI: 10.1097/00003246-200205000-00019] [Cited by in Crossref: 147] [Cited by in F6Publishing: 132] [Article Influence: 7.7] [Reference Citation Analysis]
Number Citing Articles
1 Mózsik G, Peidl Z, Szolcsányi J, Dömötör A, Hideg K, Szekeres G, Karádi O, Hunyady B. Participation of vanilloid/capsaicin receptors, calcitonin-gene-related peptide and substance P in gastric protection of omeprazole and omeprazole-like compounds. Inflammopharmacology. 2005;13:139-159. [PMID: 16259735 DOI: 10.1163/156856005774423764] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
2 Veres B, Gallyas F Jr, Varbiro G, Berente Z, Osz E, Szekeres G, Szabo C, Sumegi B. Decrease of the inflammatory response and induction of the Akt/protein kinase B pathway by poly-(ADP-ribose) polymerase 1 inhibitor in endotoxin-induced septic shock. Biochem Pharmacol 2003;65:1373-82. [PMID: 12694878 DOI: 10.1016/s0006-2952(03)00077-7] [Cited by in Crossref: 98] [Cited by in F6Publishing: 36] [Article Influence: 5.4] [Reference Citation Analysis]
3 Lal S, Snape TJ. A therapeutic update on PARP inhibitors: implications in the treatment of glioma. Drug Discov Today 2021;26:532-41. [PMID: 33157194 DOI: 10.1016/j.drudis.2020.10.029] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Mccullough LD, Zeng Z, Blizzard KK, Debchoudhury I, Hurn PD. Ischemic Nitric Oxide and Poly (ADP-Ribose) Polymerase-1 in Cerebral Ischemia: Male Toxicity, Female Protection. J Cereb Blood Flow Metab 2005;25:502-12. [DOI: 10.1038/sj.jcbfm.9600059] [Cited by in Crossref: 235] [Cited by in F6Publishing: 239] [Article Influence: 14.7] [Reference Citation Analysis]
5 Thiemermann C. Development of novel, water-soluble inhibitors of poly(adenosine 5′-diphosphate ribose) synthetase activity for use in shock and ischemia-reperfusion injury *: . Critical Care Medicine 2002;30:1163-5. [DOI: 10.1097/00003246-200205000-00038] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.4] [Reference Citation Analysis]
6 Sinha A, Katyal S, Kauppinen TM. PARP-DNA trapping ability of PARP inhibitors jeopardizes astrocyte viability: Implications for CNS disease therapeutics. Neuropharmacology 2021;187:108502. [PMID: 33631119 DOI: 10.1016/j.neuropharm.2021.108502] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Mariscalco MM. Hepatic microcirculation in ischemia/reperfusion: is there a role for poly(adenosine 5'-diphosphate-ribose) polymerases? Crit Care Med 2004;32:605-7. [PMID: 14758195 DOI: 10.1097/01.CCM.0000110668.05584.F7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
8 Ando K, Akai Y, Kunitomo J, Yokomizo T, Nakajima H, Takeuchi T, Yamashita M, Ohta S, Ohishi T, Ohishi Y. Synthesis and biological activities of novel furo[2,3,4-jk][2]benzazepin-4(3H)-one derivatives. Org Biomol Chem 2007;5:655. [DOI: 10.1039/b614510h] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
9 Fortney K, Morgen EK, Kotlyar M, Jurisica I. In silico drug screen in mouse liver identifies candidate calorie restriction mimetics. Rejuvenation Res 2012;15:148-52. [PMID: 22533420 DOI: 10.1089/rej.2011.1263] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
10 Regdon Z, Demény MA, Kovács K, Hajnády Z, Nagy-Pénzes M, Bakondi E, Kiss A, Hegedűs C, Virág L. High-content screening identifies inhibitors of oxidative stress-induced parthanatos: cytoprotective and anti-inflammatory effects of ciclopirox. Br J Pharmacol 2021;178:1095-113. [PMID: 33332573 DOI: 10.1111/bph.15344] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Gerö D, Szoleczky P, Chatzianastasiou A, Papapetropoulos A, Szabo C. Modulation of poly(ADP-ribose) polymerase-1 (PARP-1)-mediated oxidative cell injury by ring finger protein 146 (RNF146) in cardiac myocytes. Mol Med 2014;20:313-28. [PMID: 24842055 DOI: 10.2119/molmed.2014.00102] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
12 Loukili N, Rosenblatt-Velin N, Li J, Clerc S, Pacher P, Feihl F, Waeber B, Liaudet L. Peroxynitrite induces HMGB1 release by cardiac cells in vitro and HMGB1 upregulation in the infarcted myocardium in vivo. Cardiovasc Res 2011;89:586-94. [PMID: 21113057 DOI: 10.1093/cvr/cvq373] [Cited by in Crossref: 52] [Cited by in F6Publishing: 50] [Article Influence: 4.7] [Reference Citation Analysis]
13 Besson VC, Zsengellér Z, Plotkine M, Szabó C, Marchand-Verrecchia C. Beneficial effects of PJ34 and INO-1001, two novel water-soluble poly(ADP-ribose) polymerase inhibitors, on the consequences of traumatic brain injury in rat. Brain Res 2005;1041:149-56. [PMID: 15829224 DOI: 10.1016/j.brainres.2005.01.096] [Cited by in Crossref: 37] [Cited by in F6Publishing: 29] [Article Influence: 2.3] [Reference Citation Analysis]
14 Ahmad R, Rasheed Z, Ahsan H. Biochemical and cellular toxicology of peroxynitrite: implications in cell death and autoimmune phenomenon. Immunopharmacol Immunotoxicol 2009;31:388-96. [PMID: 19555204 DOI: 10.1080/08923970802709197] [Cited by in Crossref: 70] [Cited by in F6Publishing: 65] [Article Influence: 6.4] [Reference Citation Analysis]
15 Tu Z, Chu W, Zhang J, Dence CS, Welch MJ, Mach RH. Synthesis and in vivo evaluation of [11C]PJ34, a potential radiotracer for imaging the role of PARP-1 in necrosis. Nuclear Medicine and Biology 2005;32:437-43. [DOI: 10.1016/j.nucmedbio.2005.03.001] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 2.2] [Reference Citation Analysis]
16 Szenczi O, Kemecsei P, Holthuijsen MF, van Riel NA, van der Vusse GJ, Pacher P, Szabó C, Kollai M, Ligeti L, Ivanics T. Poly(ADP-ribose) polymerase regulates myocardial calcium handling in doxorubicin-induced heart failure. Biochem Pharmacol 2005;69:725-32. [PMID: 15710350 DOI: 10.1016/j.bcp.2004.11.023] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 2.4] [Reference Citation Analysis]
17 Mabley JG, Pacher P, Bai P, Wallace R, Goonesekera S, Virag L, Southan GJ, Szabó C. Suppression of intestinal polyposis in Apcmin/+ mice by targeting the nitric oxide or poly(ADP-ribose) pathways. Mutat Res 2004;548:107-16. [PMID: 15063141 DOI: 10.1016/j.mrfmmm.2004.01.006] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 1.4] [Reference Citation Analysis]
18 Oláh G, Szczesny B, Brunyánszki A, López-García IA, Gerö D, Radák Z, Szabo C. Differentiation-Associated Downregulation of Poly(ADP-Ribose) Polymerase-1 Expression in Myoblasts Serves to Increase Their Resistance to Oxidative Stress. PLoS One 2015;10:e0134227. [PMID: 26218895 DOI: 10.1371/journal.pone.0134227] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 5.3] [Reference Citation Analysis]
19 Coletta C, Módis K, Oláh G, Brunyánszki A, Herzig DS, Sherwood ER, Ungvári Z, Szabo C. Endothelial dysfunction is a potential contributor to multiple organ failure and mortality in aged mice subjected to septic shock: preclinical studies in a murine model of cecal ligation and puncture. Crit Care 2014;18:511. [PMID: 25223540 DOI: 10.1186/s13054-014-0511-3] [Cited by in Crossref: 52] [Cited by in F6Publishing: 46] [Article Influence: 7.4] [Reference Citation Analysis]
20 McCourtie AS, Farivar AS, Woolley SM, Merry HE, Wolf PS, Szabo C, Mulligan MS. Poly (ADP) ribose synthetase inhibition in alveolar macrophages undergoing hypoxia and reoxygenation. Exp Mol Pathol 2008;84:141-4. [PMID: 18206870 DOI: 10.1016/j.yexmp.2007.11.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
21 Mashimo M, Bu X, Aoyama K, Kato J, Ishiwata-Endo H, Stevens LA, Kasamatsu A, Wolfe LA, Toro C, Adams D, Markello T, Gahl WA, Moss J. PARP1 inhibition alleviates injury in ARH3-deficient mice and human cells. JCI Insight 2019;4:124519. [PMID: 30830864 DOI: 10.1172/jci.insight.124519] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
22 Mehrotra P, Krishnamurthy P, Sun J, Goenka S, Kaplan MH. Poly-ADP-ribosyl polymerase-14 promotes T helper 17 and follicular T helper development. Immunology 2015;146:537-46. [PMID: 26222149 DOI: 10.1111/imm.12515] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
23 Ahmad A, Vieira JC, de Mello AH, de Lima TM, Ariga SK, Barbeiro DF, Barbeiro HV, Szczesny B, Törö G, Druzhyna N, Randi EB, Marcatti M, Toliver-Kinsky T, Kiss A, Liaudet L, Salomao R, Soriano FG, Szabo C. The PARP inhibitor olaparib exerts beneficial effects in mice subjected to cecal ligature and puncture and in cells subjected to oxidative stress without impairing DNA integrity: A potential opportunity for repurposing a clinically used oncological drug for the experimental therapy of sepsis. Pharmacol Res 2019;145:104263. [PMID: 31071432 DOI: 10.1016/j.phrs.2019.104263] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
24 Woolley SM, Farivar AS, Naidu BV, Salzman A, Szabo C, Thomas R, Fraga C, Mulligan MS. Role of Poly (ADP) ribose synthetase in lung ischemia—reperfusion injury. The Journal of Heart and Lung Transplantation 2004;23:1290-6. [DOI: 10.1016/j.healun.2003.08.036] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
25 Nguewa PA, Fuertes MA, Valladares B, Alonso C, Pérez JM. Poly(ADP-ribose) polymerases: homology, structural domains and functions. Novel therapeutical applications. Prog Biophys Mol Biol 2005;88:143-72. [PMID: 15561303 DOI: 10.1016/j.pbiomolbio.2004.01.001] [Cited by in Crossref: 78] [Cited by in F6Publishing: 80] [Article Influence: 4.9] [Reference Citation Analysis]
26 Brunyanszki A, Olah G, Coletta C, Szczesny B, Szabo C. Regulation of mitochondrial poly(ADP-Ribose) polymerase activation by the β-adrenoceptor/cAMP/protein kinase A axis during oxidative stress. Mol Pharmacol 2014;86:450-62. [PMID: 25069723 DOI: 10.1124/mol.114.094318] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
27 Corral J, Yélamos J, Hernández-Espinosa D, Monreal Y, Mota R, Arcas I, Miñano A, Parrilla P, Vicente V. Role of lipopolysaccharide and cecal ligation and puncture on blood coagulation and inflammation in sensitive and resistant mice models. Am J Pathol 2005;166:1089-98. [PMID: 15793289 DOI: 10.1016/S0002-9440(10)62329-2] [Cited by in Crossref: 30] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
28 Liaudet L, Oddo M. Role of poly(adenosine diphosphate-ribose) polymerase 1 in septic peritonitis. Curr Opin Crit Care 2003;9:152-8. [PMID: 12657979 DOI: 10.1097/00075198-200304000-00012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
29 Szabó C. Pathophysiological aspects of cellular pyridine nucleotide metabolism: focus on the vascular endothelium. Review. Acta Physiol Hung 2003;90:175-93. [PMID: 14594189 DOI: 10.1556/APhysiol.90.2003.3.1] [Cited by in Crossref: 5] [Article Influence: 0.3] [Reference Citation Analysis]
30 Jagtap P, Szabó C. Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors. Nat Rev Drug Discov 2005;4:421-40. [PMID: 15864271 DOI: 10.1038/nrd1718] [Cited by in Crossref: 648] [Cited by in F6Publishing: 617] [Article Influence: 40.5] [Reference Citation Analysis]
31 Lohinai Z, Mabley JG, Fehér E, Marton A, Komjáti K, Szabó C. Role of the activation of the nuclear enzyme poly(ADP-ribose) polymerase in the pathogenesis of periodontitis. J Dent Res 2003;82:987-92. [PMID: 14630900 DOI: 10.1177/154405910308201210] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
32 Kunze FA, Hottiger MO. Regulating Immunity via ADP-Ribosylation: Therapeutic Implications and Beyond. Trends Immunol 2019;40:159-73. [PMID: 30658897 DOI: 10.1016/j.it.2018.12.006] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 14.0] [Reference Citation Analysis]
33 Liang D, Yu W, Nguyen N, Deschamps JR, Imler GH, Li Y, Mackerell AD, Jiang C, Xue F. Iodobenzene-Catalyzed Synthesis of Phenanthridinones via Oxidative C–H Amidation. J Org Chem 2017;82:3589-96. [DOI: 10.1021/acs.joc.7b00106] [Cited by in Crossref: 31] [Cited by in F6Publishing: 21] [Article Influence: 7.8] [Reference Citation Analysis]
34 Cuzzocrea S. Shock, inflammation and PARP. Pharmacol Res 2005;52:72-82. [PMID: 15911335 DOI: 10.1016/j.phrs.2005.02.016] [Cited by in Crossref: 63] [Cited by in F6Publishing: 61] [Article Influence: 3.9] [Reference Citation Analysis]
35 Zheng YG, Wu J, Chen Z, Goodman M. Chemical regulation of epigenetic modifications: opportunities for new cancer therapy. Med Res Rev 2008;28:645-87. [PMID: 18271058 DOI: 10.1002/med.20120] [Cited by in Crossref: 84] [Cited by in F6Publishing: 78] [Article Influence: 6.5] [Reference Citation Analysis]
36 Alano CC, Kauppinen TM, Valls AV, Swanson RA. Minocycline inhibits poly(ADP-ribose) polymerase-1 at nanomolar concentrations. Proc Natl Acad Sci U S A 2006;103:9685-90. [PMID: 16769901 DOI: 10.1073/pnas.0600554103] [Cited by in Crossref: 170] [Cited by in F6Publishing: 169] [Article Influence: 11.3] [Reference Citation Analysis]
37 Ahmad A, Gerö D, Olah G, Szabo C. Effect of endotoxemia in mice genetically deficient in cystathionine-γ-lyase, cystathionine-β-synthase or 3-mercaptopyruvate sulfurtransferase. Int J Mol Med 2016;38:1683-92. [PMID: 27748832 DOI: 10.3892/ijmm.2016.2771] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 5.8] [Reference Citation Analysis]
38 Liu J, Yan S, Cao Z, Cui S, Lin J. Synthesis of bicyclic 2-pyridones by regioselective annulations of heterocyclic ketene aminals with anhydrides. RSC Adv 2016;6:103057-64. [DOI: 10.1039/c6ra23451h] [Cited by in Crossref: 7] [Article Influence: 1.4] [Reference Citation Analysis]
39 Bartha E, Asmussen S, Olah G, Rehberg SW, Yamamoto Y, Traber DL, Szabo C. Burn and smoke injury activates poly(ADP-ribose)polymerase in circulating leukocytes. Shock 2011;36:144-8. [PMID: 21330947 DOI: 10.1097/SHK.0b013e318212988c] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
40 Garrido-Mesa N, Zarzuelo A, Gálvez J. What is behind the non-antibiotic properties of minocycline? Pharmacol Res 2013;67:18-30. [PMID: 23085382 DOI: 10.1016/j.phrs.2012.10.006] [Cited by in Crossref: 81] [Cited by in F6Publishing: 79] [Article Influence: 9.0] [Reference Citation Analysis]
41 Soriano FG, Lorigados CB, Pacher P, Szabó C. Effects of a potent peroxynitrite decomposition catalyst in murine models of endotoxemia and sepsis. Shock 2011;35:560-6. [PMID: 21263378 DOI: 10.1097/SHK.0b013e31820fe5d5] [Cited by in Crossref: 30] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
42 Wang G, Huang X, Li Y, Guo K, Ning P, Zhang Y. PARP-1 inhibitor, DPQ, attenuates LPS-induced acute lung injury through inhibiting NF-κB-mediated inflammatory response. PLoS One 2013;8:e79757. [PMID: 24278171 DOI: 10.1371/journal.pone.0079757] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 3.8] [Reference Citation Analysis]
43 Carbone M, Rossi MN, Cavaldesi M, Notari A, Amati P, Maione R. Poly(ADP-ribosyl)ation is implicated in the G0-G1 transition of resting cells. Oncogene 2008;27:6083-92. [PMID: 18663363 DOI: 10.1038/onc.2008.221] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 2.3] [Reference Citation Analysis]
44 Szijártó A, Batmunkh E, Hahn O, Mihály Z, Kreiss A, Kiss A, Lotz G, Schaff Z, Váli L, Blázovics A, Geró D, Szabó C, Kupcsulik P. Effect of PJ-34 PARP-Inhibitor on Rat Liver Microcirculation and Antioxidant Status. Journal of Surgical Research 2007;142:72-80. [DOI: 10.1016/j.jss.2006.08.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
45 Walko TD, Di Caro V, Piganelli J, Billiar TR, Clark RS, Aneja RK. Poly(ADP-ribose) polymerase 1-sirtuin 1 functional interplay regulates LPS-mediated high mobility group box 1 secretion. Mol Med. 2015;20:612-624. [PMID: 25517228 DOI: 10.2119/molmed.2014.00156] [Cited by in Crossref: 13] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
46 Szabó C. Poly (ADP-ribose) polymerase activation and circulatory shock. Novartis Found Symp 2007;280:92-103; discussion 103-7, 160-4. [PMID: 17380790 DOI: 10.1007/0-387-36005-0_16] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.1] [Reference Citation Analysis]
47 Szabó C. Poly(ADP-ribose) polymerase activation by reactive nitrogen species--relevance for the pathogenesis of inflammation. Nitric Oxide 2006;14:169-79. [PMID: 16111903 DOI: 10.1016/j.niox.2005.06.008] [Cited by in Crossref: 59] [Cited by in F6Publishing: 53] [Article Influence: 3.7] [Reference Citation Analysis]
48 Clark IA, Alleva LM, Mills AC, Cowden WB. Pathogenesis of malaria and clinically similar conditions. Clin Microbiol Rev 2004;17:509-39, table of contents. [PMID: 15258091 DOI: 10.1128/CMR.17.3.509-539.2004] [Cited by in Crossref: 126] [Cited by in F6Publishing: 61] [Article Influence: 7.4] [Reference Citation Analysis]
49 Ahmad A, Olah G, Herndon DN, Szabo C. The clinically used PARP inhibitor olaparib improves organ function, suppresses inflammatory responses and accelerates wound healing in a murine model of third-degree burn injury. Br J Pharmacol 2018;175:232-45. [PMID: 28146604 DOI: 10.1111/bph.13735] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
50 Farivar AS, Woolley SM, Naidu BV, Fraga CH, Byrne K, Thomas R, Salzman AL, Szabo CS, Mulligan MS. Poly (ADP) ribose synthetase inhibition reduces obliterative airway disease in rat tracheal allografts. The Journal of Heart and Lung Transplantation 2004;23:993-1002. [DOI: 10.1016/j.healun.2003.08.009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
51 Mabley JG, Horváth EM, Murthy KG, Zsengellér Z, Vaslin A, Benko R, Kollai M, Szabó C. Gender differences in the endotoxin-induced inflammatory and vascular responses: potential role of poly(ADP-ribose) polymerase activation. J Pharmacol Exp Ther 2005;315:812-20. [PMID: 16079296 DOI: 10.1124/jpet.105.090480] [Cited by in Crossref: 76] [Cited by in F6Publishing: 80] [Article Influence: 4.8] [Reference Citation Analysis]
52 Radi M, Vallerini GP, Petrelli A, Vincetti P, Costantino G. A one-pot two-step microwave-assisted synthesis of N1-substituted 5,6-ring-fused 2-pyridones. Tetrahedron Letters 2013;54:6905-8. [DOI: 10.1016/j.tetlet.2013.10.054] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
53 Zhou D, Chu W, Xu J, Jones LA, Peng X, Li S, Chen DL, Mach RH. Synthesis, [¹⁸F] radiolabeling, and evaluation of poly (ADP-ribose) polymerase-1 (PARP-1) inhibitors for in vivo imaging of PARP-1 using positron emission tomography. Bioorg Med Chem 2014;22:1700-7. [PMID: 24503274 DOI: 10.1016/j.bmc.2014.01.019] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 5.6] [Reference Citation Analysis]
54 Bai P, Virág L. Role of poly(ADP-ribose) polymerases in the regulation of inflammatory processes. FEBS Lett 2012;586:3771-7. [PMID: 23022557 DOI: 10.1016/j.febslet.2012.09.026] [Cited by in Crossref: 76] [Cited by in F6Publishing: 71] [Article Influence: 8.4] [Reference Citation Analysis]
55 Bai P, Hegedus C, Erdélyi K, Szabó E, Bakondi E, Gergely S, Szabó C, Virág L. Protein tyrosine nitration and poly(ADP-ribose) polymerase activation in N-methyl-N-nitro-N-nitrosoguanidine-treated thymocytes: implication for cytotoxicity. Toxicol Lett 2007;170:203-13. [PMID: 17428624 DOI: 10.1016/j.toxlet.2007.03.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
56 Islam BU, Habib S, Ali SA, Moinuddin, Ali A. Role of Peroxynitrite-Induced Activation of Poly(ADP-Ribose) Polymerase (PARP) in Circulatory Shock and Related Pathological Conditions. Cardiovasc Toxicol 2017;17:373-83. [PMID: 27990620 DOI: 10.1007/s12012-016-9394-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
57 Ekblad T, Camaioni E, Schüler H, Macchiarulo A. PARP inhibitors: polypharmacology versus selective inhibition. FEBS J 2013;280:3563-75. [DOI: 10.1111/febs.12298] [Cited by in Crossref: 57] [Cited by in F6Publishing: 53] [Article Influence: 7.1] [Reference Citation Analysis]
58 Szczesny B, Brunyanszki A, Olah G, Mitra S, Szabo C. Opposing roles of mitochondrial and nuclear PARP1 in the regulation of mitochondrial and nuclear DNA integrity: implications for the regulation of mitochondrial function. Nucleic Acids Res 2014;42:13161-73. [PMID: 25378300 DOI: 10.1093/nar/gku1089] [Cited by in Crossref: 55] [Cited by in F6Publishing: 52] [Article Influence: 7.9] [Reference Citation Analysis]
59 Fang Y, Tranmer GK. Continuous flow photochemistry as an enabling synthetic technology: synthesis of substituted-6(5H)-phenanthridinones for use as poly(ADP-ribose) polymerase inhibitors. Med Chem Commun 2016;7:720-4. [DOI: 10.1039/c5md00552c] [Cited by in Crossref: 17] [Article Influence: 3.4] [Reference Citation Analysis]
60 Handy J. Mitochondrial Dysfunction in Sepsis. In: Vincent J, editor. Yearbook of Intensive Care and Emergency Medicine 2005. New York: Springer; 2005. pp. 402-11. [DOI: 10.1007/0-387-26272-5_35] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
61 Tuntevski K, Hajira A, Nichols A, Alway SE, Mohamed JS. Muscle-specific sirtuin1 gain-of-function ameliorates skeletal muscle atrophy in a pre-clinical mouse model of cerebral ischemic stroke. FASEB Bioadv 2020;2:387-97. [PMID: 32676579 DOI: 10.1096/fba.2020-00017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
62 Beneke S, Cohausz O, Malanga M, Boukamp P, Althaus F, Bürkle A. Rapid regulation of telomere length is mediated by poly(ADP-ribose) polymerase-1. Nucleic Acids Res 2008;36:6309-17. [PMID: 18835851 DOI: 10.1093/nar/gkn615] [Cited by in Crossref: 61] [Cited by in F6Publishing: 58] [Article Influence: 4.7] [Reference Citation Analysis]
63 Minchenko AG, Stevens MJ, White L, Abatan OI, Komjáti K, Pacher P, Szabó C, Obrosova IG. Diabetes-induced overexpression of endothelin-1 and endothelin receptors in the rat renal cortex is mediated via poly(ADP-ribose) polymerase activation. FASEB J 2003;17:1514-6. [PMID: 12824290 DOI: 10.1096/fj.03-0013fje] [Cited by in Crossref: 76] [Cited by in F6Publishing: 71] [Article Influence: 4.2] [Reference Citation Analysis]
64 Castillo-Juárez I, Maeda T, Mandujano-Tinoco EA, Tomás M, Pérez-Eretza B, García-Contreras SJ, Wood TK, García-Contreras R. Role of quorum sensing in bacterial infections. World J Clin Cases 2015; 3(7): 575-598 [PMID: 26244150 DOI: 10.12998/wjcc.v3.i7.575] [Cited by in CrossRef: 100] [Cited by in F6Publishing: 83] [Article Influence: 16.7] [Reference Citation Analysis]
65 Shimoda K, Murakami K, Enkhbaatar P, Traber LD, Cox RA, Hawkins HK, Schmalstieg FC, Komjati K, Mabley JG, Szabo C, Salzman AL, Traber DL. Effect of poly(ADP ribose) synthetase inhibition on burn and smoke inhalation injury in sheep. Am J Physiol Lung Cell Mol Physiol 2003;285:L240-9. [PMID: 12626333 DOI: 10.1152/ajplung.00319.2002] [Cited by in Crossref: 71] [Cited by in F6Publishing: 63] [Article Influence: 3.9] [Reference Citation Analysis]
66 Haikarainen T, Narwal M, Joensuu P, Lehtiö L. Evaluation and Structural Basis for the Inhibition of Tankyrases by PARP Inhibitors. ACS Med Chem Lett 2014;5:18-22. [PMID: 24900770 DOI: 10.1021/ml400292s] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 3.6] [Reference Citation Analysis]
67 Turgeon Z, Jørgensen R, Visschedyk D, Edwards PR, Legree S, McGregor C, Fieldhouse RJ, Mangroo D, Schapira M, Merrill AR. Newly discovered and characterized antivirulence compounds inhibit bacterial mono-ADP-ribosyltransferase toxins. Antimicrob Agents Chemother. 2011;55:983-991. [PMID: 21135177 DOI: 10.1128/aac.01164-10] [Cited by in Crossref: 27] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
68 Stone DH, Conrad MF, Albadawi H, Entabi F, Stoner MC, Cambria RP, Watkins MT. Effect of PJ34 on spinal cord tissue viability and gene expression in a murine model of thoracic aortic reperfusion injury. Vasc Endovascular Surg 2009;43:444-51. [PMID: 19640911 DOI: 10.1177/1538574409333582] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
69 Castiel A, Visochek L, Mittelman L, Zilberstein Y, Dantzer F, Izraeli S, Cohen-Armon M. Cell death associated with abnormal mitosis observed by confocal imaging in live cancer cells. J Vis Exp 2013;:e50568. [PMID: 23995751 DOI: 10.3791/50568] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
70 Geraets L, Moonen HJ, Brauers K, Wouters EF, Bast A, Hageman GJ. Dietary flavones and flavonoles are inhibitors of poly(ADP-ribose)polymerase-1 in pulmonary epithelial cells. J Nutr 2007;137:2190-5. [PMID: 17884996 DOI: 10.1093/jn/137.10.2190] [Cited by in F6Publishing: 87] [Reference Citation Analysis]
71 Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev. 2007;87:315-424. [PMID: 17237348 DOI: 10.1152/physrev.00029.2006] [Cited by in Crossref: 3817] [Cited by in F6Publishing: 3471] [Article Influence: 272.6] [Reference Citation Analysis]
72 Hegedűs C, Lakatos P, Kiss-Szikszai A, Patonay T, Gergely S, Gregus A, Bai P, Haskó G, Szabó É, Virág L. Cytoprotective dibenzoylmethane derivatives protect cells from oxidative stress-induced necrotic cell death. Pharmacol Res 2013;72:25-34. [PMID: 23523665 DOI: 10.1016/j.phrs.2013.03.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
73 Pacher P, Szabó C. Role of poly(ADP-ribose) polymerase-1 activation in the pathogenesis of diabetic complications: endothelial dysfunction, as a common underlying theme. Antioxid Redox Signal. 2005;7:1568-1580. [PMID: 16356120 DOI: 10.1089/ars.2005.7.1568] [Cited by in Crossref: 112] [Cited by in F6Publishing: 108] [Article Influence: 7.5] [Reference Citation Analysis]
74 Mota RA, Sánchez-Bueno F, Saenz L, Hernández-Espinosa D, Jimeno J, Tornel PL, Martínez-Torrano A, Ramírez P, Parrilla P, Yélamos J. Inhibition of poly(ADP-ribose) polymerase attenuates the severity of acute pancreatitis and associated lung injury. Lab Invest. 2005;85:1250-1262. [PMID: 16127429 DOI: 10.1038/labinvest.3700326] [Cited by in Crossref: 49] [Cited by in F6Publishing: 52] [Article Influence: 3.3] [Reference Citation Analysis]
75 Szabo C, Martins V, Liaudet L. Poly(ADP-Ribose) Polymerase Inhibition in Acute Lung Injury. A Reemerging Concept. Am J Respir Cell Mol Biol 2020;63:571-90. [PMID: 32640172 DOI: 10.1165/rcmb.2020-0188TR] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
76 Long CA, Boulom V, Albadawi H, Tsai S, Yoo HJ, Oklu R, Goldman MH, Watkins MT. Poly-ADP-ribose-polymerase inhibition ameliorates hind limb ischemia reperfusion injury in a murine model of type 2 diabetes. Ann Surg 2013;258:1087-95. [PMID: 23549425 DOI: 10.1097/SLA.0b013e31828cced3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
77 Szanto A, Hellebrand EE, Bognar Z, Tucsek Z, Szabo A, Gallyas F Jr, Sumegi B, Varbiro G. PARP-1 inhibition-induced activation of PI-3-kinase-Akt pathway promotes resistance to taxol. Biochem Pharmacol 2009;77:1348-57. [PMID: 19426673 DOI: 10.1016/j.bcp.2009.01.008] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 3.0] [Reference Citation Analysis]
78 Gerö D, Szabó C. Poly(ADP-ribose) polymerase: a new therapeutic target? Curr Opin Anaesthesiol 2008;21:111-21. [PMID: 18443476 DOI: 10.1097/ACO.0b013e3282f63c15] [Cited by in Crossref: 30] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
79 Lehtiö L, Jemth AS, Collins R, Loseva O, Johansson A, Markova N, Hammarström M, Flores A, Holmberg-Schiavone L, Weigelt J, Helleday T, Schüler H, Karlberg T. Structural basis for inhibitor specificity in human poly(ADP-ribose) polymerase-3. J Med Chem 2009;52:3108-11. [PMID: 19354255 DOI: 10.1021/jm900052j] [Cited by in Crossref: 72] [Cited by in F6Publishing: 66] [Article Influence: 6.0] [Reference Citation Analysis]
80 Chacon-cabrera A, Mateu-jimenez M, Langohr K, Fermoselle C, García-arumí E, Andreu AL, Yelamos J, Barreiro E. Role of PARP activity in lung cancer-induced cachexia: Effects on muscle oxidative stress, proteolysis, anabolic markers, and phenotype. J Cell Physiol 2017;232:3744-61. [DOI: 10.1002/jcp.25851] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 8.0] [Reference Citation Analysis]
81 Crawford RS, Albadawi H, Atkins MD, Jones JE, Yoo HJ, Conrad MF, Austen WG Jr, Watkins MT. Postischemic poly (ADP-ribose) polymerase (PARP) inhibition reduces ischemia reperfusion injury in a hind-limb ischemia model. Surgery 2010;148:110-8. [PMID: 20132957 DOI: 10.1016/j.surg.2009.12.006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
82 Casey PJ, Black JH, Szabo C, Frosch M, Albadawi H, Chen M, Cambria RP, Watkins MT. Poly(adenosine diphosphate ribose) polymerase inhibition modulates spinal cord dysfunction after thoracoabdominal aortic ischemia-reperfusion. J Vasc Surg 2005;41:99-107. [PMID: 15696051 DOI: 10.1016/j.jvs.2004.10.040] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
83 Black JH, Casey PJ, Albadawi H, Cambria RP, Watkins MT. Poly adenosine diphosphate-ribose polymerase inhibitor PJ34 abolishes systemic proinflammatory responses to thoracic aortic ischemia and reperfusion. J Am Coll Surg 2006;203:44-53. [PMID: 16798486 DOI: 10.1016/j.jamcollsurg.2006.04.004] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
84 Lobo SM, Orrico SR, Queiroz MM, Cunrath GS, Chibeni GS, Contrin LM, Cury PM, Burdmann EA, de Oliveira Machado AM, Togni P, De Backer D, Preiser JC, Szabó C, Vincent JL. Pneumonia-induced sepsis and gut injury: effects of a poly-(ADP-ribose) polymerase inhibitor. J Surg Res 2005;129:292-7. [PMID: 16139303 DOI: 10.1016/j.jss.2005.05.018] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
85 Murakami K, Enkhbaatar P, Shimoda K, Cox RA, Burke AS, Hawkins HK, Traber LD, Schmalstieg FC, Salzman AL, Mabley JG, Komjáti K, Pacher P, Zsengellér Z, Szabó C, Traber DL. Inhibition of poly (ADP-ribose) polymerase attenuates acute lung injury in an ovine model of sepsis. Shock 2004;21:126-33. [PMID: 14752285 DOI: 10.1097/01.shk.0000108397.56565.4a] [Cited by in Crossref: 57] [Cited by in F6Publishing: 60] [Article Influence: 3.4] [Reference Citation Analysis]
86 Goldfarb RD, Marton A, Szabó É, Virág L, Salzman AL, Glock D, Akhter I, Mccarthy R, Parrillo JE, Szabó C. Protective effect of a novel, potent inhibitor of poly(adenosine 5′-diphosphate-ribose) synthetase in a porcine model of severe bacterial sepsis*: . Critical Care Medicine 2002;30:974-80. [DOI: 10.1097/00003246-200205000-00004] [Cited by in Crossref: 76] [Cited by in F6Publishing: 74] [Article Influence: 4.0] [Reference Citation Analysis]
87 Tasatargil A, Dalaklioglu S, Sadan G. Inhibition of poly(ADP-ribose) polymerase prevents vascular hyporesponsiveness induced by lipopolysaccharide in isolated rat aorta. Pharmacological Research 2005;51:581-6. [DOI: 10.1016/j.phrs.2005.02.020] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
88 Hamahata A, Enkhbaatar P, Lange M, Yamaki T, Sakurai H, Shimoda K, Nakazawa H, Traber LD, Traber DL. Administration of poly(ADP-ribose) polymerase inhibitor into bronchial artery attenuates pulmonary pathophysiology after smoke inhalation and burn in an ovine model. Burns 2012;38:1210-5. [PMID: 22995423 DOI: 10.1016/j.burns.2012.08.021] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
89 Bai P, Hegedus C, Szabó E, Gyüre L, Bakondi E, Brunyánszki A, Gergely S, Szabó C, Virág L. Poly(ADP-ribose) polymerase mediates inflammation in a mouse model of contact hypersensitivity. J Invest Dermatol 2009;129:234-8. [PMID: 18633442 DOI: 10.1038/jid.2008.196] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
90 Conrad M, Angeli JP, Vandenabeele P, Stockwell BR. Regulated necrosis: disease relevance and therapeutic opportunities. Nat Rev Drug Discov 2016;15:348-66. [PMID: 26775689 DOI: 10.1038/nrd.2015.6] [Cited by in Crossref: 275] [Cited by in F6Publishing: 273] [Article Influence: 55.0] [Reference Citation Analysis]
91 Lobo SM, De Backer D, Sun Q, Tu Z, Dimopoulos G, Preiser JC, Nagy N, Vray B, Vercruy V, Terzi RG, Vincent JL. Gut mucosal damage during endotoxic shock is due to mechanisms other than gut ischemia. J Appl Physiol (1985). 2003;95:2047-2054. [PMID: 12923122 DOI: 10.1152/japplphysiol.00925.2002] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.3] [Reference Citation Analysis]
92 Du X, Matsumura T, Edelstein D, Rossetti L, Zsengellér Z, Szabó C, Brownlee M. Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells. J Clin Invest 2003;112:1049-57. [PMID: 14523042 DOI: 10.1172/JCI18127] [Cited by in Crossref: 334] [Cited by in F6Publishing: 231] [Article Influence: 18.6] [Reference Citation Analysis]
93 Geraets L, Moonen HJ, Brauers K, Gottschalk RW, Wouters EF, Bast A, Hageman GJ. Flavone as PARP-1 inhibitor: its effect on lipopolysaccharide induced gene-expression. Eur J Pharmacol 2007;573:241-8. [PMID: 17643414 DOI: 10.1016/j.ejphar.2007.07.013] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
94 Sodhi RK, Singh N, Jaggi AS. Poly(ADP-ribose) polymerase-1 (PARP-1) and its therapeutic implications. Vascular Pharmacology 2010;53:77-87. [DOI: 10.1016/j.vph.2010.06.003] [Cited by in Crossref: 77] [Cited by in F6Publishing: 72] [Article Influence: 7.0] [Reference Citation Analysis]
95 Pacher P, Liaudet L, Bai P, Virag L, Mabley JG, Haskó G, Szabó C. Activation of poly(ADP-ribose) polymerase contributes to development of doxorubicin-induced heart failure. J Pharmacol Exp Ther. 2002;300:862-867. [PMID: 11861791 DOI: 10.1124/jpet.300.3.862] [Cited by in Crossref: 131] [Cited by in F6Publishing: 123] [Article Influence: 6.9] [Reference Citation Analysis]
96 Curtin NJ, Szabo C. Poly(ADP-ribose) polymerase inhibition: past, present and future. Nat Rev Drug Discov 2020;19:711-36. [PMID: 32884152 DOI: 10.1038/s41573-020-0076-6] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 37.0] [Reference Citation Analysis]
97 Faltz M, Bergin H, Pilavachi E, Grimwade G, Mabley JG. Effect of the Anti-retroviral Drugs Efavirenz, Tenofovir and Emtricitabine on Endothelial Cell Function: Role of PARP. Cardiovasc Toxicol 2017;17:393-404. [PMID: 28050758 DOI: 10.1007/s12012-016-9397-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
98 Devalaraja-Narashimha K, Singaravelu K, Padanilam BJ. Poly(ADP-ribose) polymerase-mediated cell injury in acute renal failure. Pharmacol Res 2005;52:44-59. [PMID: 15911333 DOI: 10.1016/j.phrs.2005.02.022] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 2.6] [Reference Citation Analysis]
99 Módis K, Gerő D, Stangl R, Rosero O, Szijártó A, Lotz G, Mohácsik P, Szoleczky P, Coletta C, Szabó C. Adenosine and inosine exert cytoprotective effects in an in vitro model of liver ischemia-reperfusion injury. Int J Mol Med. 2013;31:437-446. [PMID: 23232950 DOI: 10.3892/ijmm.2012.1203] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
100 Horváth EM, Benko R, Gero D, Kiss L, Szabó C. Treatment with insulin inhibits poly(ADP-ribose)polymerase activation in a rat model of endotoxemia. Life Sci 2008;82:205-9. [PMID: 18078960 DOI: 10.1016/j.lfs.2007.11.001] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
101 Zhou JL, Jin GH, Yi YL, Zhang JL, Huang XL. Role of nitric oxide and peroxynitrite anion in lung injury induced by intestinal ischemia-reperfusion in rats. World J Gastroenterol 2003; 9(6): 1318-1322 [PMID: 12800248 DOI: 10.3748/wjg.v9.i6.1318] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 36] [Article Influence: 1.9] [Reference Citation Analysis]
102 Martínez-Morcillo FJ, Cantón-Sandoval J, Martínez-Menchón T, Corbalán-Vélez R, Mesa-Del-Castillo P, Pérez-Oliva AB, García-Moreno D, Mulero V. Non-canonical roles of NAMPT and PARP in inflammation. Dev Comp Immunol 2021;115:103881. [PMID: 33038343 DOI: 10.1016/j.dci.2020.103881] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
103 Ferraris DV. Evolution of poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors. From concept to clinic. J Med Chem 2010;53:4561-84. [PMID: 20364863 DOI: 10.1021/jm100012m] [Cited by in Crossref: 235] [Cited by in F6Publishing: 215] [Article Influence: 21.4] [Reference Citation Analysis]
104 Paquet-Durand F, Silva J, Talukdar T, Johnson LE, Azadi S, van Veen T, Ueffing M, Hauck SM, Ekström PA. Excessive activation of poly(ADP-ribose) polymerase contributes to inherited photoreceptor degeneration in the retinal degeneration 1 mouse. J Neurosci 2007;27:10311-9. [PMID: 17881537 DOI: 10.1523/JNEUROSCI.1514-07.2007] [Cited by in Crossref: 85] [Cited by in F6Publishing: 48] [Article Influence: 6.1] [Reference Citation Analysis]
105 Yang D, Zhang W, Song L, Guo F. Andrographolide protects against cigarette smoke-induced lung inflammation through activation of heme oxygenase-1. J Biochem Mol Toxicol 2013;27:259-65. [PMID: 23629921 DOI: 10.1002/jbt.21483] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
106 Módis K, Gero D, Erdélyi K, Szoleczky P, DeWitt D, Szabo C. Cellular bioenergetics is regulated by PARP1 under resting conditions and during oxidative stress. Biochem Pharmacol 2012;83:633-43. [PMID: 22198485 DOI: 10.1016/j.bcp.2011.12.014] [Cited by in Crossref: 56] [Cited by in F6Publishing: 58] [Article Influence: 5.6] [Reference Citation Analysis]
107 Rajesh M, Mukhopadhyay P, Bátkai S, Godlewski G, Haskó G, Liaudet L, Pacher P. Pharmacological inhibition of poly(ADP-ribose) polymerase inhibits angiogenesis. Biochem Biophys Res Commun 2006;350:352-7. [PMID: 17007818 DOI: 10.1016/j.bbrc.2006.09.049] [Cited by in Crossref: 48] [Cited by in F6Publishing: 46] [Article Influence: 3.2] [Reference Citation Analysis]
108 Hegedus C, Lakatos P, Oláh G, Tóth BI, Gergely S, Szabó E, Bíró T, Szabó C, Virág L. Protein kinase C protects from DNA damage-induced necrotic cell death by inhibiting poly(ADP-ribose) polymerase-1. FEBS Lett 2008;582:1672-8. [PMID: 18439913 DOI: 10.1016/j.febslet.2008.04.023] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
109 Módis K, Gero D, Nagy N, Szoleczky P, Tóth ZD, Szabó C. Cytoprotective effects of adenosine and inosine in an in vitro model of acute tubular necrosis. Br J Pharmacol 2009;158:1565-78. [PMID: 19906119 DOI: 10.1111/j.1476-5381.2009.00432.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 3.0] [Reference Citation Analysis]
110 Di Paola R, Mazzon E, Muià C, Terrana D, Greco S, Britti D, Santori D, Oteri G, Cordasco G, Cuzzocrea S. 5-aminoisoquinolin-1(2H)-one, a water-soluble poly (ADP-ribose) polymerase (PARP) inhibitor reduces the evolution of experimental periodontitis in rats. J Clin Periodontol 2007;34:95-102. [DOI: 10.1111/j.1600-051x.2006.01016.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
111 Farivar AS, Woolley SM, Fraga CH, Thomas R, Salzman AL, Szabo C, Mulligan MS. Intratracheal poly (ADP) ribose synthetase inhibition ameliorates lung ischemia reperfusion injury. The Annals of Thoracic Surgery 2004;77:1938-43. [DOI: 10.1016/j.athoracsur.2003.10.120] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
112 Yates SP, Taylor PL, Jørgensen R, Ferraris D, Zhang J, Andersen GR, Merrill AR. Structure-function analysis of water-soluble inhibitors of the catalytic domain of exotoxin A from Pseudomonas aeruginosa. Biochem J 2005;385:667-75. [PMID: 15458385 DOI: 10.1042/BJ20041480] [Cited by in Crossref: 36] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
113 Curtin NJ, Szabo C. Therapeutic applications of PARP inhibitors: anticancer therapy and beyond. Mol Aspects Med 2013;34:1217-56. [PMID: 23370117 DOI: 10.1016/j.mam.2013.01.006] [Cited by in Crossref: 235] [Cited by in F6Publishing: 219] [Article Influence: 29.4] [Reference Citation Analysis]
114 Szabó C, Pacher P, Zsengellér Z, Vaslin A, Komjáti K, Benkö R, Chen M, Mabley JG, Kollai M. Angiotensin II-mediated endothelial dysfunction: role of poly(ADP-ribose) polymerase activation. Mol Med 2004;10:28-35. [PMID: 15502880 DOI: 10.2119/2004-00001.szabo] [Cited by in Crossref: 60] [Cited by in F6Publishing: 28] [Article Influence: 3.8] [Reference Citation Analysis]
115 Helyar SG, Patel B, Headington K, El Assal M, Chatterjee PK, Pacher P, Mabley JG. PCB-induced endothelial cell dysfunction: role of poly(ADP-ribose) polymerase. Biochem Pharmacol 2009;78:959-65. [PMID: 19549508 DOI: 10.1016/j.bcp.2009.06.019] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 2.2] [Reference Citation Analysis]
116 Ruan Q, Ruan J, Zhang W, Qian F, Yu Z. Targeting NAD+ degradation: The therapeutic potential of flavonoids for Alzheimer's disease and cognitive frailty. Pharmacol Res 2018;128:345-58. [PMID: 28847709 DOI: 10.1016/j.phrs.2017.08.010] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
117 Clark IA, Cowden WB. The pathophysiology of falciparum malaria. Pharmacol Ther 2003;99:221-60. [PMID: 12888113 DOI: 10.1016/s0163-7258(03)00060-3] [Cited by in Crossref: 125] [Cited by in F6Publishing: 54] [Article Influence: 6.9] [Reference Citation Analysis]
118 Li J, McCullough LD. Sex differences in minocycline-induced neuroprotection after experimental stroke. J Cereb Blood Flow Metab 2009;29:670-4. [PMID: 19190654 DOI: 10.1038/jcbfm.2009.3] [Cited by in Crossref: 82] [Cited by in F6Publishing: 74] [Article Influence: 6.8] [Reference Citation Analysis]
119 Komissarov AA, Karaseva MA, Roschina MP, Shubin AV, Lunina NA, Kostrov SV, Demidyuk IV. Individual Expression of Hepatitis A Virus 3C Protease Induces Ferroptosis in Human Cells In Vitro. Int J Mol Sci 2021;22:7906. [PMID: 34360671 DOI: 10.3390/ijms22157906] [Reference Citation Analysis]
120 Lee YR, Yu DS, Liang YC, Huang KF, Chou SJ, Chen TC, Lee CC, Chen CL, Chiou SH, Huang HS. New approaches of PARP-1 inhibitors in human lung cancer cells and cancer stem-like cells by some selected anthraquinone-derived small molecules. PLoS One 2013;8:e56284. [PMID: 23451039 DOI: 10.1371/journal.pone.0056284] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
121 Pacher P, Cziráki A, Mabley JG, Liaudet L, Papp L, Szabó C. Role of poly(ADP-ribose) polymerase activation in endotoxin-induced cardiac collapse in rodents. Biochem Pharmacol 2002;64:1785-91. [PMID: 12445868 DOI: 10.1016/s0006-2952(02)01421-1] [Cited by in Crossref: 38] [Cited by in F6Publishing: 10] [Article Influence: 2.1] [Reference Citation Analysis]
122 Ungerstedt JS, Blömback M, Söderström T. Nicotinamide is a potent inhibitor of proinflammatory cytokines. Clin Exp Immunol 2003;131:48-52. [PMID: 12519385 DOI: 10.1046/j.1365-2249.2003.02031.x] [Cited by in Crossref: 121] [Cited by in F6Publishing: 121] [Article Influence: 6.7] [Reference Citation Analysis]
123 Iványi Z, Hauser B, Pittner A, Asfar P, Vassilev D, Nalos M, Altherr J, Brückner UB, Szabó C, Radermacher P, Fröba G. Systemic and hepatosplanchnic hemodynamic and metabolic effects of the PARP inhibitor PJ34 during hyperdynamic porcine endotoxemia. Shock 2003;19:415-21. [PMID: 12744483 DOI: 10.1097/01.shk.0000048904.46342.22] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
124 Kauppinen T, Swanson R. The role of poly(ADP-ribose) polymerase-1 in CNS disease. Neuroscience 2007;145:1267-72. [DOI: 10.1016/j.neuroscience.2006.09.034] [Cited by in Crossref: 102] [Cited by in F6Publishing: 106] [Article Influence: 7.3] [Reference Citation Analysis]
125 Pagano A, Métrailler-Ruchonnet I, Aurrand-Lions M, Lucattelli M, Donati Y, Argiroffo CB. Poly(ADP-ribose) polymerase-1 (PARP-1) controls lung cell proliferation and repair after hyperoxia-induced lung damage. Am J Physiol Lung Cell Mol Physiol 2007;293:L619-29. [PMID: 17575013 DOI: 10.1152/ajplung.00037.2007] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
126 Pellicciari R, Camaioni E, Costantino G. 3. Life or death decisions: the cast of poly(ADP-ribose)polymerase (PARP) as a therapeutic target for brain ischaemia. Prog Med Chem 2004;42:125-69. [PMID: 15003720 DOI: 10.1016/S0079-6468(04)42003-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
127 Kiss L, Szabó C. The pathogenesis of diabetic complications: the role of DNA injury and poly(ADP-ribose) polymerase activation in peroxynitrite-mediated cytotoxicity. Mem Inst Oswaldo Cruz 2005;100 Suppl 1:29-37. [PMID: 15962096 DOI: 10.1590/s0074-02762005000900007] [Cited by in Crossref: 25] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
128 Barreiro E, Gea J. PARP-1 and PARP-2 activity in cancer-induced cachexia: potential therapeutic implications. Biol Chem 2018;399:179-86. [PMID: 29016348 DOI: 10.1515/hsz-2017-0158] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
129 Beneke S. Poly(ADP-ribose) polymerase activity in different pathologies--the link to inflammation and infarction. Exp Gerontol 2008;43:605-14. [PMID: 18511226 DOI: 10.1016/j.exger.2008.04.008] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 2.3] [Reference Citation Analysis]
130 Riley JP, Kulkarni A, Mehrotra P, Koh B, Perumal NB, Kaplan MH, Goenka S. PARP-14 binds specific DNA sequences to promote Th2 cell gene expression. PLoS One 2013;8:e83127. [PMID: 24376650 DOI: 10.1371/journal.pone.0083127] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
131 Pacher P, Szabó C. Role of poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases: the therapeutic potential of PARP inhibitors. Cardiovasc Drug Rev 2007;25:235-60. [PMID: 17919258 DOI: 10.1111/j.1527-3466.2007.00018.x] [Cited by in Crossref: 203] [Cited by in F6Publishing: 194] [Article Influence: 15.6] [Reference Citation Analysis]
132 Aneja RK, Sjodin H, Gefter JV, Zingarelli B, Delude RL. Small interfering RNA mediated Poly (ADP-ribose) Polymerase-1 inhibition upregulates the heat shock response in a murine fibroblast cell line. J Inflamm (Lond) 2011;8:3. [PMID: 21345219 DOI: 10.1186/1476-9255-8-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]